Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates
Top Cited Papers
- 1 January 2021
- Vol. 184 (2) , 370-383.e13
Abstract
No abstract availableKeywords
Funding Information
- Beijing Nova Program
This publication has 66 references indexed in Scilit:
- The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary proteinBiochemical Journal, 2010
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7–10Biochemical Journal, 2010
- Studies on the DIDS-binding Site of Monocarboxylate Transporter 1 Suggest a Homology Model of the Open Conformation and a Plausible Translocation CycleJournal of Biological Chemistry, 2009
- MolProbity: all-atom contacts and structure validation for proteins and nucleic acidsNucleic Acids Research, 2007
- The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activityMolecular Membrane Biology, 2006
- Automated acquisition of cryo-electron micrographs for single particle reconstruction on an FEI Tecnai electron microscopeJournal of Structural Biology, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994